Transitioning psoriasis patients to adalimumab following a suboptimal response to etanercept, methotrexate, or phototherapy: efficacy and safety results from an open-label study

被引：0
|
作者：
Strober, B. [1 ]
Poulin, Y. [2 ]
Kerdel, F. [3 ]
Langley, R. [4 ]
Menter, A. [5 ]
Papp, K. [6 ]
Gu, Y. [7 ]
Okun, M. [7 ]
机构：
[1] NYU, Sch Med, New York, NY USA
[2] Ctr Dermatol Quebec Metropolitain, Quebec City, PQ, Canada
[3] Florida Acad Dermatol Ctr, Miami, FL USA
[4] Dalhousie Univ, Halifax, NS, Canada
[5] Baylor Psoriasis Res Inst, Dallas, TX USA
[6] Clin Res, Waterloo, ON, Canada
[7] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2010年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P021
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [31] Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III
    Suhler, Eric B.
    Adan, Alfredo
    Brezin, Antoine P.
    Fortin, Eric
    Goto, Hiroshi
    Jaffe, Glenn J.
    Kaburaki, Toshikatsu
    Kramer, Michal
    Lim, Lyndell L.
    Muccioli, Cristina
    Quan Dong Nguyen
    Van Calster, Joachim
    Cimino, Luca
    Kron, Martina
    Song, Alexandra P.
    Liu, Jianzhong
    Pathai, Sophia
    Camez, Anne
    Schlaen, Ariel
    van Velthoven, Mirjam E. J.
    Vitale, Albert T.
    Zierhut, Manfred
    Tari, Samir
    Dick, Andrew D.
    OPHTHALMOLOGY, 2018, 125 (07) : 1075 - 1087
  • [32] Adalimumab in patients with Crohn's disease -: safety and efficacy in an open-label single centre study
    Seiderer, J.
    Brand, S.
    Dambacher, J.
    Pfennig, S.
    Juergens, M.
    Goeke, B.
    Ochsenkuehn, T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (07) : 787 - 796
  • [33] A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis
    Kobayashi, Shigeto
    Harigai, Masayoshi
    Mozaffarian, Neelufar
    Pangan, Aileen L.
    Sharma, Shringi
    Brown, L. Steven
    Miyasaka, Nobuyuki
    MODERN RHEUMATOLOGY, 2012, 22 (04) : 589 - 597
  • [34] Adalimumab treatment in Japanese patients with generalized pustular psoriasis: Results of an open-label phase 3 study
    Morita, Akimichi
    Yamazaki, Fumikazu
    Matsuyama, Takashi
    Takahashi, Kenzo
    Arai, Satoru
    Asahina, Akihiko
    Imafuku, Shinichi
    Nakagawa, Hidemi
    Hasegawa, Yuichi
    Williams, David
    Matsuda, Naoto
    Kitamura, Susumu
    JOURNAL OF DERMATOLOGY, 2018, 45 (12): : 1371 - 1380
  • [35] Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL
    Gordon, Kenneth
    Papp, Kim
    Poulin, Yves
    Gu, Yihua
    Rozzo, Stephen
    Sasso, Eric H.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (02) : 241 - 251
  • [36] Adalimumab (Humira®) improves nail psoriasis in PsA:: results from large, open-label study (stereo)
    Van den Bosch, F.
    Reece, R.
    Behrens, F.
    Wendling, D.
    Mikkelsen, K.
    Frank, M.
    Kron, M.
    Kupper, H.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2007, 21 : 51 - 52
  • [37] An open-label study to evaluate the efficacy of retreatment of patients with psoriasis who have previously been treated with etanercept
    Vitiello, Magalys
    Abuchar, Adriana
    Grant, Annika
    Kerdel, Francisco
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB35 - AB35
  • [38] Efficacy and safety of adalimumab in patients with plaque psoriasis who failed to show a satisfactory response to etanercept
    Bissonnette, Robert
    Bolduc, Chantal
    Guenther, Lyn
    Poulin, Yves
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB171 - AB171
  • [39] Results from an open-label extension study of etanercept in ankylosing spondylitis
    Davis, J
    Webb, A
    Lund, S
    Sack, K
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (02): : 302 - 304
  • [40] Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanercept
    Bissonnette, Robert
    Bolduc, Chantal
    Poulin, Yves
    Guenther, Lyn
    Lynde, Charles W.
    Maari, Catherine
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 63 (02) : 228 - 234
12345